Stay updated with breaking news from Ir External Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- Patent broadly covers technology to select neoantigens that are presented by HLA molecules determined to be present in a patient's tumor - - Patent applies to any modality, including vaccine and
Investegate announcements from Achilles Therapeutics PLC, Achilles Therapeutics Announces Grant of US Patent Covering the Treatment of Patients with an Immunotherapy Targeting Neoantigens Based on Tumor HLA Status
Achilles ADSs will continue to trade on the Nasdaq Global Select Market at this time, and the Company’s operations are not affected by the receipt of the...
Investegate announcements from Syncona Limited, Achilles reports Q4 and full year 2022 Results
- Early proof-of-concept data support durable clinical benefit including confirmed partial response and stable disease in heavily pre-treated patients with advanced NSCLC - - Safety and tolerability